Table 3: Drugs that Induce Brugada ECG Pattern (Type 1 ST-Segment Elevation) and that Should be Avoided in Patients with Brugada Syndrome.
Drug | Class | Clinical use | References | |
---|---|---|---|---|
Antidepressants | ||||
Tricyclic Antidepressant | Amitriptyline | IIA | Depression | 85, 87 |
Desipramine | IIA | Depression | 70, 86 | |
Nortriptyline | IIA | Depression | 72, 88 | |
Clomipramine | IIA | Depression/ obsessive compulsive disorder |
||
Imipramine | IIA | Depression/ anxiety |
||
Tetracyclic Antidepressant | Maprotiline | IIA | Depression/ anxiety |
87 |
Others | Lithium | IIB | Depression | 82 |
Bupropion Cyamemazine Dosulepin Doxepin Fluoxetin Fluvoxamine Maprotiline Paroxetine Lamotrigine |
IIB | Depression Depression Depression Depression Depression Depression Depression Depression Depression Epilepsy, bipolar disorder |
143 | |
Antipsychotics | Trifluoperazine IIA |
IIA | Anxiety, psychotic disorders |
85 |
Loxapine | IIA | Psychotic conditions including hallucinations, delusions, and confusion |
144 | |
Clotiapine Cyamemazine Thioridazine |
IIB | Psychotic disorders | ||
Antiepileptic | Propofol | IIA | Sedative, hypnotic and antiepileptic |
83, 84 |
Recommendation class: Class I: There is evidence and/or general agreement that a given drug is potentially arrhythmic in BrS patients. Class IIA: There is conflicting evidence and/or divergence of opinion about the drug, but the weight of evidence/opinion is in favour of a potentially arrhythmic effect in BrS patients. Class IIB: There is conflicting evidence and/or divergence of opinion about the drug, and the potential arrhythmic effect in BrS patients is less well established by evidence/opinion. BrS = Brugada syndrome. Source: Modified from www.brugadadrugs.org.